pmc logo image
A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice
Gunther Spohn, Gary T Jennings, Byron EE Martina, Iris Keller, Markus Beck, Paul Pumpens, Albert DME Osterhaus, Martin F Bachmann
Virol J. 2010; 7: 146. Published online 2010 July 6. doi: 10.1186/1743-422X-7-146
PMCID:
PMC2914671
Abstract Full Text PDF–723K
 Is Cited by the Following 2 Articles in this Archive:
Immunodominance and Functional Activities of Antibody Responses to Inactivated West Nile Virus and Recombinant Subunit Vaccines in Mice
Juergen Zlatkovic, Karin Stiasny, Franz X. Heinz
J Virol. 2011 March; 85(5): 1994–2003. Published online 2010 December 8. doi: 10.1128/JVI.01886-10
PMCID:
PMC3067796
Abstract Full Text PDF–1.5M
Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
Luis M Branco, Jessica N Grove, Frederick J Geske, Matt L Boisen, Ivana J Muncy, Susan A Magliato, Lee A Henderson, Randal J Schoepp, Kathleen A Cashman, Lisa E Hensley, Robert F Garry
Virol J. 2010; 7: 279. Published online 2010 October 20. doi: 10.1186/1743-422X-7-279
PMCID:
PMC2984592
Abstract Full Text PDF–3.4M Supplementary Material
You are here: NCBI > Literature > PubMed Central
Write to the Help Desk